Serum urate association with hypertension in young adults: Analysis from the Coronary Artery Risk Development in Young Adults cohort

Angelo L. Gaffo, David R. Jacobs, Femke Sijtsma, Cora E. Lewis, Ted R Mikuls, Kenneth G. Saag

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective To determine if serum urate concentration is associated with development of hypertension in young adults. Methods Retrospective cohort analysis from 4752 participants with available serum urate and without hypertension at baseline from the Coronary Artery Risk Development in Young Adults (CARDIA) study; a mixed race (African-American and White) cohort established in 1985 with 20 years of follow-up data for this analysis. Associations between baseline serum urate concentration and incident hypertension (defined as a blood pressure greater or equal to 140/90 or being on antihypertensive drugs) were investigated in sex-stratified bivariate and multivariable Cox-proportional analyses. Results Mean age (SD) at baseline was 24.8 (3.6) years for men and 24.9 (3.7) years for women. Compared with the referent category, we found a greater hazard of developing hypertension starting at 345 mmol/l (5.8 mg/dl) of serum urate for men and 214 mmol/l (3.6 mg/dl) for women. There was a 25% increase in the hazard of developing hypertension in men (HR1.25 (95% CI 1.15 to 1.36)) per each mg/dl increase in serum urate but no significant increase in women (HR 1.06 (95%CI 0.97 to 1.16)). Conclusions We found a significant independent association between higher serum urate concentrations and the subsequent hazard of incident hypertension, even at concentrations below the conventional hyperuricaemia threshold of 404 mmol/l (6.8 mg/dl).

Original languageEnglish (US)
Pages (from-to)1321-1327
Number of pages7
JournalAnnals of the rheumatic diseases
Volume72
Issue number8
DOIs
StatePublished - Aug 1 2013

Fingerprint

Uric Acid
Young Adult
Coronary Vessels
Hypertension
Serum
Hazards
Blood pressure
African Americans
Antihypertensive Agents
Cohort Studies
Blood Pressure

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Serum urate association with hypertension in young adults : Analysis from the Coronary Artery Risk Development in Young Adults cohort. / Gaffo, Angelo L.; Jacobs, David R.; Sijtsma, Femke; Lewis, Cora E.; Mikuls, Ted R; Saag, Kenneth G.

In: Annals of the rheumatic diseases, Vol. 72, No. 8, 01.08.2013, p. 1321-1327.

Research output: Contribution to journalArticle

Gaffo, Angelo L. ; Jacobs, David R. ; Sijtsma, Femke ; Lewis, Cora E. ; Mikuls, Ted R ; Saag, Kenneth G. / Serum urate association with hypertension in young adults : Analysis from the Coronary Artery Risk Development in Young Adults cohort. In: Annals of the rheumatic diseases. 2013 ; Vol. 72, No. 8. pp. 1321-1327.
@article{7c2e9bb855ee40eca4cab42b4866f8a7,
title = "Serum urate association with hypertension in young adults: Analysis from the Coronary Artery Risk Development in Young Adults cohort",
abstract = "Objective To determine if serum urate concentration is associated with development of hypertension in young adults. Methods Retrospective cohort analysis from 4752 participants with available serum urate and without hypertension at baseline from the Coronary Artery Risk Development in Young Adults (CARDIA) study; a mixed race (African-American and White) cohort established in 1985 with 20 years of follow-up data for this analysis. Associations between baseline serum urate concentration and incident hypertension (defined as a blood pressure greater or equal to 140/90 or being on antihypertensive drugs) were investigated in sex-stratified bivariate and multivariable Cox-proportional analyses. Results Mean age (SD) at baseline was 24.8 (3.6) years for men and 24.9 (3.7) years for women. Compared with the referent category, we found a greater hazard of developing hypertension starting at 345 mmol/l (5.8 mg/dl) of serum urate for men and 214 mmol/l (3.6 mg/dl) for women. There was a 25{\%} increase in the hazard of developing hypertension in men (HR1.25 (95{\%} CI 1.15 to 1.36)) per each mg/dl increase in serum urate but no significant increase in women (HR 1.06 (95{\%}CI 0.97 to 1.16)). Conclusions We found a significant independent association between higher serum urate concentrations and the subsequent hazard of incident hypertension, even at concentrations below the conventional hyperuricaemia threshold of 404 mmol/l (6.8 mg/dl).",
author = "Gaffo, {Angelo L.} and Jacobs, {David R.} and Femke Sijtsma and Lewis, {Cora E.} and Mikuls, {Ted R} and Saag, {Kenneth G.}",
year = "2013",
month = "8",
day = "1",
doi = "10.1136/annrheumdis-2012-201916",
language = "English (US)",
volume = "72",
pages = "1321--1327",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - Serum urate association with hypertension in young adults

T2 - Analysis from the Coronary Artery Risk Development in Young Adults cohort

AU - Gaffo, Angelo L.

AU - Jacobs, David R.

AU - Sijtsma, Femke

AU - Lewis, Cora E.

AU - Mikuls, Ted R

AU - Saag, Kenneth G.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Objective To determine if serum urate concentration is associated with development of hypertension in young adults. Methods Retrospective cohort analysis from 4752 participants with available serum urate and without hypertension at baseline from the Coronary Artery Risk Development in Young Adults (CARDIA) study; a mixed race (African-American and White) cohort established in 1985 with 20 years of follow-up data for this analysis. Associations between baseline serum urate concentration and incident hypertension (defined as a blood pressure greater or equal to 140/90 or being on antihypertensive drugs) were investigated in sex-stratified bivariate and multivariable Cox-proportional analyses. Results Mean age (SD) at baseline was 24.8 (3.6) years for men and 24.9 (3.7) years for women. Compared with the referent category, we found a greater hazard of developing hypertension starting at 345 mmol/l (5.8 mg/dl) of serum urate for men and 214 mmol/l (3.6 mg/dl) for women. There was a 25% increase in the hazard of developing hypertension in men (HR1.25 (95% CI 1.15 to 1.36)) per each mg/dl increase in serum urate but no significant increase in women (HR 1.06 (95%CI 0.97 to 1.16)). Conclusions We found a significant independent association between higher serum urate concentrations and the subsequent hazard of incident hypertension, even at concentrations below the conventional hyperuricaemia threshold of 404 mmol/l (6.8 mg/dl).

AB - Objective To determine if serum urate concentration is associated with development of hypertension in young adults. Methods Retrospective cohort analysis from 4752 participants with available serum urate and without hypertension at baseline from the Coronary Artery Risk Development in Young Adults (CARDIA) study; a mixed race (African-American and White) cohort established in 1985 with 20 years of follow-up data for this analysis. Associations between baseline serum urate concentration and incident hypertension (defined as a blood pressure greater or equal to 140/90 or being on antihypertensive drugs) were investigated in sex-stratified bivariate and multivariable Cox-proportional analyses. Results Mean age (SD) at baseline was 24.8 (3.6) years for men and 24.9 (3.7) years for women. Compared with the referent category, we found a greater hazard of developing hypertension starting at 345 mmol/l (5.8 mg/dl) of serum urate for men and 214 mmol/l (3.6 mg/dl) for women. There was a 25% increase in the hazard of developing hypertension in men (HR1.25 (95% CI 1.15 to 1.36)) per each mg/dl increase in serum urate but no significant increase in women (HR 1.06 (95%CI 0.97 to 1.16)). Conclusions We found a significant independent association between higher serum urate concentrations and the subsequent hazard of incident hypertension, even at concentrations below the conventional hyperuricaemia threshold of 404 mmol/l (6.8 mg/dl).

UR - http://www.scopus.com/inward/record.url?scp=84880232785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880232785&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2012-201916

DO - 10.1136/annrheumdis-2012-201916

M3 - Article

C2 - 22984170

AN - SCOPUS:84880232785

VL - 72

SP - 1321

EP - 1327

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 8

ER -